drugset / Trial / NCT01345942

A Study on the Effect of Food on the Pharmacokinetics of RO5428029 in Healthy Volunteers

NCT01345942 ↗

Phase 1 Completed 12 enrolled Hoffmann-La Roche
Non-randomizedCrossoverOpen-label

Summary

This open label, two period, crossover study will evaluate the safety and the effect of food on the pharmacokinetics of RO5428029 in healthy volunteers. In a crossover design, healthy subjects will be randomized to receive a single oral dose of RO5428029 with or without food, with a washout period of at least 7 days between dosing and a follow-up of 7 to 10 days after last dose. Anticipated time on study will be up to 21 days.

Timeline

Start
2011-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject RO5428029 Small molecule — Oral

Indications

No indication recorded.